To confirm that CASP1 acts as a downstream target of PRMT5, we evaluated protein expression levels of CASP1 and cleaved-CASP1 in MM cell lines after transfection with PRMT5-shRNA-2 compared to the negative control groups. Here, PRMT5 is linked to Miyoshi myopathy.